Report overview
Chronic idiopathic constipation is a highly prevalent functional bowel disorder that affects millions of individuals worldwide. Some of the major factors that contribute to the burgeoning number of patients suffering from chronic idiopathic constipation include sedentary lifestyle, increasing usage of anti-inflammatory agents, and drastic decline in the intake of dietary fibers. Over the past few years, considerable efforts have been made to improve the management of chronic idiopathic constipation.
This report aims to provide a comprehensive presentation of the global market for Chronic Idiopathic Constipation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Idiopathic Constipation Treatment. This report contains market size and forecasts of Chronic Idiopathic Constipation Treatment in global, including the following market information:
Global Chronic Idiopathic Constipation Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Chronic Idiopathic Constipation Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Blood Tests Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chronic Idiopathic Constipation Treatment include Bayer AG, Allergan, Bausch Health, Sanofi, Takeda Pharmaceutical Company, SEBELA PHARMACEUTICALS, Ironwood Pharmaceuticals, Inc., Albireo Pharma, Inc. and Sucampo Pharmaceuticals, Inc. (Mallinckrodt), etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Idiopathic Constipation Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Idiopathic Constipation Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Chronic Idiopathic Constipation Treatment Market Segment Percentages, by Type, 2023 (%)
Blood Tests
Sigmoidoscopy
Colonoscopy
Balloon Expulsion Test
Anorectal Manometry
Colonic Transit Study
Defecography
Others
Global Chronic Idiopathic Constipation Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Chronic Idiopathic Constipation Treatment Market Segment Percentages, by Application, 2023 (%)
Hospitals
Gastroenterology clinics
Diagnostic Centers
Others
Global Chronic Idiopathic Constipation Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Chronic Idiopathic Constipation Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Idiopathic Constipation Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Chronic Idiopathic Constipation Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Allergan
Bausch Health
Sanofi
Takeda Pharmaceutical Company
SEBELA PHARMACEUTICALS
Ironwood Pharmaceuticals, Inc.
Albireo Pharma, Inc.
Sucampo Pharmaceuticals, Inc. (Mallinckrodt)
Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Idiopathic Constipation Treatment, market overview.
Chapter 2: Global Chronic Idiopathic Constipation Treatment market size in revenue.
Chapter 3: Detailed analysis of Chronic Idiopathic Constipation Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Idiopathic Constipation Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
